Divisions of "Chest Medicine and 2Thoracic Surgery and Departments of 31nternal Medicine, 4Surgery and 5Pathology, Taichung Veterans General Hospital, Taichung, and 6National Yang-Ming University, Taipei, Taiwan Background: Traditional pleurodesis for malignant pleural effusion is performed by large-bore chest tube insertion with the instillation of sclerosing agents after the compressed lung re-expansion and pleural fluid drainage of 100-150 ml/day. This study was carried out to evaluate the possibility of rapid sclerotherapy for malignant pleural effusions by insertion of a small-bore Elecath tube (12-French) under ultrasound guidance and intrapleural injection of bleomycin 60 IU. Methods: Twenty-six patients, with 28 cytopathologically proven malignant pleural effusions (two patients had bilateral pleural effusions) and receiving the insertion of the Elecath tube for drainage, were included in our series. This rapid and short-term sclerosing method was performed and completed by intrapleural injection of bleomycin when the pleural effusion had been clearly drained by the small-bore Elecath tube and the compressed lung had fully re-expanded on follow-up chest radiographs. Results: Twenty patients with 22 pleural effusions underwent the intrapleural injection of bleomycin, with the results of pleurodesis being complete response 41% (9/22), partial response 36% (8/22) and failure 23% (5/22). Interestingly, among the 17 successful procedures of pleurodesis (complete response and partial response), 71% (12) procedures could be completed within 2 days (seven within one day and five within 2 days). The remaining unsuccessful procedures carried out on six patients without the injection of bleomycin were due to a non-re-expanded lung (n =3) and inadequate drainage (n =3); of these, four patients also received the large-bore chest tube insertion after the removal of the Elecath tube, but the compressed lung still could not re-expand. Conclusion: The method of rapid sclerotherapy for malignant pleural effusions by small-bore Elecath tube is promising, with a success rate achieving 77%, usually within 2 days.
INTRODUCTION
Malignant tumors complicated with malignant pleural effusions are frequently encountered by chest physicians. Because the development of malignant pleural effusion usually compromises the patients' life quality and presents a far-advanced stage of underlying malignancies, the goal of treatment is directed to palliative management of the accumulated effusion 0-3). In order to relieve severe dyspnea caused by massive pleural effusion, simple thoracentesis and/or chest tube thoracostomy, followed by pleurodesis with various sclerosing agents, are traditionally used (4-7). However, fluid reaccumulation is often frequent and rapid after simple thoracentesis and excessive protein loss and increasing incidence of pleural infection may occur after repeated aspiration (4, 5) ; hence large-bore chest tube thoracostomy with instillation of sclerosing agents for pleurodesis, especially tetracycline and bleomycin, has been documented to be an appropriate and standard treatment method (7) (8) (9) .
Recently, image (fluoroscopy. computed tomography, ultrasoundi-guided percutaneous small-bore catheter drainage of accumulated fluid has been proved to be useful and successful (10) (11) (12) (13) . Furthermore, sclerotherapy for malignant pleural effusion by small-bore catheter is also excellent and just as effective as sclerotherapy by large-bore chest tube (14) (15) (16) . In the literature, many factors have been reported to influence the results of pleurodesis, such as re-expansion of the compressed lung, the characteristics of the pleural effusion (PH, glucose, LDH), the Small-bore Elccath tube insertion f or sclerotherapy of malignant pleural effusion amount of fluid drainageper day, the sclerosing agents,etc. (7. 15, 17, 18) and the question of whether pleural fluid adequately drained with full re-expansion of the compressed lung and fluid drainage at $100-150 ml/dayis necessary for successful pleurodesis or only pleural fluid adequately drained with the compressed lung re-expansion is successful has still not been adequately resolved or discussed.
In this paper, we report our results on rapid sclerotherapy for malignant pleural effusion by small-bore catheter (one-step Elecath tube) under ultrasound guidance. 'Rapid sclerotherapy' means that the pleurodesis is performed when the pleural fluid is adequately drained with the compressed lung in full re-expansion and the small-bore Elecath tube is immediately removed 2 h later after the intrapleural injection of bleomycin (the volume of fluid drainage per day is not considered). The aim was to evaluate the possibility of rapid sclerotherapy for malignant pleural effusion by the small-bore Elecath tube.
MATERIALS AND METHODS
From July 1992 to October 1995, we prospectively used a small-bore one-step Elecath tube (12-French, Electro-Catheter, NJ, USA) to drain malignant pleural effusion under ultrasound guidance and injected bleomycin for pleurodesis when the pleural effusion was completely drained and the compressed lung had fully re-expanded. The small-bore one-step Elecath tube has an inner stylet with a sharp tip which makes insertionthrough a local incision easy and direct. The patients enrolled for pleurodesis in our series met the following criteria: (1) proven malignant pleural effusion cytologically or histologically, (2) respiratory distress due to pleural effusion requiring thoracentesis, (3) without central lesions and bleeding tendency (platelets~100 000/mm 3 ), (4) a life expectancy of 30 days (Karnofsky scale perfomance status 60) and (5) cooperative. During this period, there was a total of 26 consecutive patients, with 28 cytologically (11 = 26, from pleural effusions) or histologically (11 = 2, from percutaneous needle biopsy of pleural masses) proven malignant pleural effusions (two patients had bilateral pleural effusion), undergoing the small-bore Elecath tube insertion for pleurodesis.The patients consisted of 16 men and 10 women, ranging in age from 31 to 78 (mean = 62). The primary underlying malignancies were lung cancer (11 = 20) , breast cancer (11 = 1), gastric cancer (/1 = 1), cervical cancer (11 = 1), renal cell carcinoma (n = I), hypopharyngeal cancer (n =I) and carcinoma of unknown origin (n =1).
To perform small-bore Elecath tube insertion for pleurodesis, we used ultrasound (SAL-38B, Toshiba,Tokyo,Japan) to localize the most suitable dependent portion along the posterior axillary line after obtaining the patient's informed consent. The skin was first locally sterilized with aquamous betadine and 75% alcohol and then a one-step Elecath tube was inserted through a small cutaneous incision after local anesthesia (14, 15) . When the Elecath tube had been inserted smoothly, it was connected to a three-way stopcock and a nephrostomy drainage bag (Tri-Fortune Hospital Supply, Taiwan)for the control of fluid drainage ( Fig. 1) , then the fluid drainage was kept at 200 ml/h for the first 10h. After the drainage of~2000 ml of fluid or when chest discomfort and/or dyspnea developed in the patient, the fluid drainage was changed to 200 mIl2 h. When the fluid drainage was less than 200 ml/h or 200 ml per 2 h, the three-way stopcock was kept open continuously for adequate drainage. During the duration of the Elecath tube insertion, we used chest radiographs and/or ultrasound to follow the patient's condition every day (14) (15) (16) . When the pleural effusion was clearly drained and the compressed lung had fully re-expanded, intrapleural injection of bleomycin for pleurodesis was performed immediately: 10 ml of 2°ln xylocaine were first injected intrapleurally from the Elecath tube, followed by 60 IV of bleomycin (dissolved in 60 ml of normal saline) and finally 15 ml of normal saline for flushing. After the fluid and drug injection, we asked the patient to change position every 15 min for 2 h and then the Elecathtube was removed immediately (15, 16) .
In our series, pleurodesis was performed when the pleural fluid was adequately drained and the compressed lung was in full re-expansion (we did not wait for fluid drainage at $100-150 ml/day, as suggested in traditional pleurodesis): furthermore, the small-bore Elecath tube was also immediately removed 2 h after the intrapleural injection of bleomycin. Hence, most patients receiving the procedurefor pleurodesiscould have their treatment completed within 2 days.
The responseof pleurodesis was defined based on findings from 30-day follow-up chest radiographs as (I) complete response, i.e. no reaccumulation of pleural effusion, (2) partial response, i.e. fluid reaccumulation above the post-sclerotherapy level but below i.nitial presentation, not requiring thoracentesis for respiratory distress, or (3) failure,i.e.fluid reaccumulation to the levelof initial presentation or requiring thoracentesis for respiratory distress.
RESULTS
Among 26 patients with 28 malignant pleural effusions receiving the small-bore Elecath tube insertion, 20 patients with 22 malignant pleural effusions underwent 22 procedures of intrapleural injection of bleomycin for pleurodesis, with the results being complete response in nine [41% (9/22)J, partial response in . Among the 17 successful procedures of pleurodesis (complete response and partial response), the duration of the small-bore Elecath tube insertion was I day (n = 7), 2 days (n = 5), 4 days (n = 2), 5 days (n = 1), 6 days (n = I) and 10 days (n = I). Thus, 12 (71%) procedures could be completed within 2 days (seven within I day and five within 2 days) (Fig. 2) . In the failed procedure s of pleurodesis, the duration of the small-bore Elecath tube insertion was I day (n = 3), 4 days (n = I) and 16 days (n = I). Of these, one patient had complete pleural fluid drainage with the compressed lung in full re-expansion on the sixteenth day; however, the subsequent pleu rodesis still failed. The characteristics and responses of the patien ts undergoing small-bore Elecath tube insertion are shown in Table I and the duration of the small-bore Elecath tube insertion in each procedure is given in Table 2 in detail.
The remaining six patients did not undergo the procedure of intrapleural injection of bleomycin for pleurodesis, owing to inadequate drainage (n = 3) and a non-re-expanded lung (11 = 3). All these six patients also had the small-bore Elecath tube inserted for only 2 days (Table 2 ). In patients with non-re-expanded lungs (n = 3), the pleural fluid was clearly drained within I day; unfortunately, the non-re-expanded lung made the follow-up chest radiographs show pneumothorax. In patients with inadequate drainage (n = 3), the pleural fluid could not be drained smoothly, so the small-bore Elecath tube was removed within 2 days. Interest ingly, four patients also received the large-bore chest tube insertion again; nevertheless, the compressed lung (n = 3) still could not re-expand and the pleural fluid (n = I) was still inadequately drained ( 
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DISCUSSION
In traditional pleurodesis using a large-bore chest tube or small-bore catheter thoracostomy, sclerotherapy is usually performed when the pleural fluid is adequately drained, the compressed lung is in full re-expansion and the daily volume of fluid drainage is below 100-150 ml (3, 6, 9) . Our study shows that 'rapid sclerotherapy' for malignant pleural effusion by smallbore tube is promising, with successful pleurodesis usually completed within 2 days and with acceptable results. Hence intrapleural injection of sclerosing agents for pleurodesis can be performed immediately when the pleural fluid is clearly drained and the compressed lung is in full re-expansion, The traditional concern about the volume of daily fluid drainage after tube thoracostomy is not necessary.
Villanueva et aI. (19) reported their results of short-term sclerotherapy (the procedure for pleurodesis in their study group was similar to the procedure that we used, but the sclerosing agent was tetracycline) for malignant pleural effusion by chest tube thoracostomy, with the results of short -term sclerotherapy being effective as the standard traditional sclerotherapy. In our series, we chose bleomycin as the sclerosing agent instead of tetracycline, because bleomycin injection into the pleural cavity is less painful and produces a shorter duration of fever than tetracycline injection. In addition, tetracycline is now less readily available. Nevertheless, our results not only confirm the report of Villanueva et aI., but also reveal that small-bore tube thoracostomy for short-term and rapid sclerotherapy is successful. Although the numbers in our series of studies and those of Villanueva et aI. are small, we believe that this short-term and rapid sclerotherapy is worthy of clinical application, because it reduces the cost, discomfort and duration of a patient's admission. Certainly, a large series study in the future is necessary and would be helpful in making our results more convincing.
Another point we should discuss is the application of the suction apparatus. In earlier work on small-bore catheter insertion for pleurodesis, a suction device was connected to the small-bore catheter for adequate drainage (14) (15) (16) . Undoubtedly, the action of suction will make the fluid drain more easily and completely. However, as mentioned above, the rate of successful pleurodesis in our series is 77% (17/22); if the remaining six patients, who did not undergo pleurodesis, are also included, the success rate is only around 61% (17/28). Because we used only a small-bore Elecath tube, a three-way stopcock and a nephrostomy drainage bag for fluid drainage, the suction apparatus described earlier (14) (15) (16) was not used in our series. Whether a suction apparatus would influence the adequate drainage of pleural fluid and the results of pleurodesis needs a further controlled study; it is indeed an interesting question. Nevertheless, among 20 patients with 22 malignant pleural effusions receiving small-bore Elecath tube insertion for pleurodesis, all showed smooth and clear fluid drainage without the use of any suction apparatus (Fig. 2) .
We had four patients with complications that resulted from non-re-expanded lungs (n =3) or inadequate drainage (n =1)after small-bore tube insertion, who also received large-bore chest tube thoracostomies with standard water-sealed suction. Unfortunately, the compressed lung (n =3) still could not re-expand and the inadequate drainage (n = 1) also persisted. Thus, in patients undergoing small-bore tube insertion for sclerotherapy with non-re-expanded lung and/or inadequate drainage, whether or not large-bore chest tube thoracostomy would be helpful also needs further study.
Regarding the complications of small-bore tube insertion for intrapleural injection of bleomycin for sclerotherapy, some side effects have been reported, including fever, hemoptysis, nausea, vomiting and diarrhea (8, 9, 20) . In our series, some side effects also occurred after intrapleural injection of bleomycin, such as fever, vomiting and hiccups. However, the high incidence of fever [77% (17/22)] in our series surprised us. In other reported studies, the occurrence of fever after bleomycin injection was low. We do not understand why fever developed so often in our series. Fortunately, it was always low-grade and usually subsided within 24h.
Although image (fluoroscopy, ultrasound, computed tomography)-guided small-bore catheter drainage of accumulated fluid has been demonstrated to be valuable and successful, in our experience, focusing on the localization of pleural effusion, ultrasound is the most appropriate image guidance method (15) . Apparently, fluoroscopy and computed tomography sometimes cannot assess the most adequate and dependent position of pleural effusion in real time. For patients suffering from severe dyspnea and/or who have hemithorax opacification on chest radiographs, it is difficult to lie flat on a bed for computed tomography examination or to evaluate the diaphragmatic motion by fluoroscopy on such patients. However, ultrasound can detect and localize the pleural effusion and diaphragmatic motion easily in real time and thus mark the area for tube insertion more conveniently. We strongly recommend ultrasound as the first choice of image guidance for pleural fluid localization and small-bore tube insertion.
In conclusion, ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion is promising, with the procedure of sclerotherapy usually being completed within 2 days and with acceptable results. We believe that this rapid sclerotherapy method is worthy of wide clinical application and that it can reduce costs, discomfort and the duration of patients' admission. A large series study is necessary to confirm our results.
